Kim Sablich

Insider Reports History

Location
Brisbane, CA
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kimbely Sablich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Sablich:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jazz Pharmaceuticals plc EVP, GM of U.S. Ordinary Shares 28,478 $3,392,584 $119.13 05 Jun 2023 Direct
Eiger BioPharmaceuticals, Inc. Director Common Stock 6,000 $1,786 $0.2977 11 Mar 2022 Direct
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 28,000 01 Mar 2023 Direct

Insider Reports Filed by Kim Sablich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JAZZ Jazz Pharmaceuticals plc 05 Jun 2023 1 -$270,098 4 EVP, GM of U.S. 07 Jun 2023, 19:15
JAZZ Jazz Pharmaceuticals plc 08 Mar 2023 2 -$421,043 4 EVP, GM of U.S., Commercial Ma 10 Mar 2023, 17:10
JAZZ Jazz Pharmaceuticals plc 03 Mar 2023 2 -$229,876 4 EVP, GM of U.S., Commercial Ma 07 Mar 2023, 19:50
EIGR Eiger BioPharmaceuticals, Inc. 01 Mar 2023 1 $0 4 Director 03 Mar 2023, 19:50
JAZZ Jazz Pharmaceuticals plc 06 Jun 2022 7 -$842,429 4 EVP & GM, North America 08 Jun 2022, 16:56
EIGR Eiger BioPharmaceuticals, Inc. 11 Mar 2022 2 $0 4 Director 11 Mar 2022, 20:06
JAZZ Jazz Pharmaceuticals plc 03 Mar 2022 2 -$114,854 4 EVP & GM, North America 09 Mar 2022, 17:05
JAZZ Jazz Pharmaceuticals plc 11 Nov 2021 1 -$371,000 4 EVP & GM, North America 15 Nov 2021, 18:30
JAZZ Jazz Pharmaceuticals plc 05 Jun 2021 1 -$256,234 4 EVP & GM, North America 09 Jun 2021, 18:55